JORDAN BIO-INDUSTRIES CENTER

What JORDAN BIO-INDUSTRIES CENTER does

JOVAC (Jordan Bio-Industries Centre Co.) is a privately held veterinary vaccine manufacturer headquartered in Amman, Jordan, established in 1986 as a joint project between the Government of the Hashemite Kingdom of Jordan and the German Government (represented by GTZ). The company manufactures veterinary vaccines and biological diagnostic reagents for poultry and large animals, operating a portfolio of 48 vaccines covering 40 diseases. Its capabilities span both freeze-dried live attenuated vaccines and inactivated oil emulsion vaccines for injection, with separate product lines organized into poultry and large animal categories.

JOVAC distributes its products through an international distributor network across 48 countries, complemented by direct relationships with government veterinary services and partnerships with international organizations such as FAO and IRC-Geneva. The company is ISO 9001 certified since 2003 (renewed annually by Lloyd Register/LRQA) and holds Jordanian GMP certification along with GMP certificates from multiple regional and overseas regulatory authorities. Customer segments include commercial poultry farmers, large animal farmers (cattle, sheep, goats, camels), and government/institutional buyers for national disease control programs. The company is led by CEO Raad Dayem.

Revenue is generated through one-time sales of vaccine products to distributors and institutional/government buyers, with pricing conducted on a quotation basis. The go-to-market motion is primarily channel-partner driven, with distribution reach across 48 countries globally. No public revenue figures are disclosed, and the company operates as a private joint government-private venture with no parent company or subsidiaries reported.

Name

JORDAN BIO-INDUSTRIES CENTER

Legal name

Jordan Bio-Industries Centre Co.

Website

https://jovaccenter.com

Company type

Private

Founded year

1986

Operating status

Operating

Headcount range

11–50 employees

Short description

JOVAC (Jordan Bio-Industries Centre) is a Jordan-based veterinary vaccine manufacturer founded in 1986 as a Jordanian-German government joint venture. It produces 48 vaccines covering 40 diseases for poultry and large animals, distributing to 48 countries via international distributors and government/institutional partners.

Ownership category

akta.pro rank

Product category

Veterinary Vaccines

SIC

Biological Products, (No Disgnostic Substances) (2836)

akta.pro primary industry

Veterinary Vaccines (Biologics) (HLAMAEAL)

akta.pro secondary industries

Poultry Vaccines (HLAMAKAC), Livestock Vaccines (Cattle, Swine, Sheep & Goats) (HLAMAKAB), Vaccine Technology Platforms (Live, Inactivated, Subunit, Vector, mRNA/DNA) (HLAMAKAH), Vaccine Manufacturing & Contract Services (Veterinary Vaccine CDMO) (HLAMAKAI)

Keywords

• Veterinary vaccines
• Poultry vaccines
• Livestock vaccines
• Biological diagnostics
• Animal health products

Headquarters

HQ city

Amman

HQ country

Jordan

HQ region

Middle East

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Operations, Personnel, Supply Chain, Technology or R&D, Infrastructure, Marketing or Sales

Revenue model

1. Veterinary Vaccine Sales: JOVAC generates revenue through the sale of veterinary vaccines and biological products to local and international markets. The company manufactures and supplies veterinary vaccines for Poultry and Farm animals, selling to distributors and government agencies across 48 countries.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

JOVAC manufactures and supplies veterinary vaccines and biological diagnostic reagents for poultry and large animals, producing 48 different vaccines covering 40 diseases. The product portfolio includes live attenuated freeze-dried vaccines and inactivated oil emulsion vaccines for injection, alongside serological and technical services for farmers. The company serves 48 countries globally through distributors and institutional/government channels.

Product overview

JOVAC (Jordan Bio-Industries Centre) is a veterinary vaccine manufacturer offering a comprehensive portfolio of vaccines organized into two main categories: Poultry vaccines and Large Animal (Livestock) vaccines. The Poultry portfolio includes live attenuated vaccines such as Jovac NDV B1, Jovac NDV Clone, Jovac NDV La Sota, Jovac NDV I2, Jovac IB H120, Jovac IBD D78, Combivac, Combivac C, Combivac L, Avipox, and Gallovac 9R; and inactivated vaccines including the Jova Zeit product line (Jova Zeit 1, Jova Zeit 1 Forte, Jova Zeit 1,2, Jova Zeit 1,3, Jova Zeit 1,6, Jova Zeit 1,6 Plus, Jova Zeit 1,7, Jova Zeit 1,2,3,5, Jova Zeit 1,2,4, Jova Zeit 4, Jova Zeit 5, Jova Zeit 6 Premium, Jova Zeit 7, Jova Zeit H5N8) and Jovasalm E. The Large Animal portfolio includes live attenuated vaccines such as LumpyShield, LumpyShield-N, Caprivac, K&P Vac, Jovivac, Jovivac RF, Pestevac, Brucevac variants, Bruce19vac, Jovaplasm B, and Anthravac; and inactivated vaccines including Jovaclost, Jovaclost T, Jovaclost T&P, Jovapast, Botivac, and Black Quarter. Products are available in various presentations (doses) and are distributed internationally to 48 countries.

Differentiator

Problem solved

Functional benefit

Products and services

• Poultry Live Attenuated Vaccines Freeze-dried live attenuated poultry vaccines delivered to commercial poultry farmers and the poultry industry via distributors. Protects poultry against Newcastle Disease, Infectious Bronchitis, Infectious Bursal Disease (Gumboro), Fowl Pox, and Salmonella.
• Poultry Inactivated Vaccines (Jova Zeit line and Jovasalm E) Inactivated oil emulsion injectable poultry vaccines for commercial poultry farmers covering Newcastle Disease, Infectious Bronchitis, Infectious Bursal Disease, Egg Drop Syndrome, Reovirus, Fowl Adenovirus, Avian Influenza (H9N2, H5N8), and Salmonella enteritidis; offered as single and combined/multivalent formulations.
• Large Animal Live Attenuated Vaccines Freeze-dried live attenuated livestock vaccines for cattle, sheep, goats, camels, buffalo, and horses, covering Lumpy Skin Disease, Goat Pox, Sheep Pox, Peste des petits ruminants (PPR), Brucellosis, Contagious Bovine Pleuropneumonia (CBPP), and Anthrax. Sold to large animal farmers and government veterinary services.
• Large Animal Inactivated Vaccines Inactivated suspension-for-injection adsorbed vaccines for cattle, sheep, goats, camels, and horses, covering Contagious Caprine Pleuropneumonia (CCPP), Clostridial diseases, Pasteurellosis, Botulism, and Blackleg (Black Quarter). Sold to large animal farmers and government veterinary departments.
• Biological Diagnostic Reagents Biological diagnostic reagents produced alongside vaccines for veterinary diagnostic use, supporting disease detection and surveillance. Targeted at veterinary laboratories, government animal health programs, and distributors.
• Serological and Technical Services Serological testing and technical advisory services delivered to poultry and large animal farmers, complementing vaccine sales and supporting vaccination program effectiveness.

Quantifiable outcome

• Exports to 48 countries globally
• +2 more outcomes

Named customers1 record

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Six partnerships are on record, tiered core and minor.

• FAO (Food and Agriculture Organization)coreStrategic or Co-development PartnerFAO partnership for international veterinary vaccine supply and animal health programs. JOVAC appears as a partner/sponsor in FAO-related initiatives for livestock disease control.
• IRC-Geneva (International Red Cross)coreStrategic or Co-development PartnerPartnership with IRC-Geneva for community health service programs related to veterinary health.
• MOA (Ministry of Agriculture, Jordan)coreStrategic or Co-development PartnerJordan Ministry of Agriculture partnership for national veterinary vaccine supply and agricultural development programs.
• Jordan University of Science and TechnologyminorStrategic or Co-development PartnerAcademic partnership for research cooperation and technical staff development in veterinary vaccine technology.
• GTZ (German Development Agency) - HistoricalcoreStrategic or Co-development PartnerOriginal founding partner in 1986 joint project between Government of Jordan and German Government for establishing JOVAC as a veterinary vaccine manufacturing facility.
• MCC (Mekong Capital Company)minorStrategic or Co-development PartnerListed as partner/sponsor organization in JOVAC's ecosystem.

Scale indicators4 records

Recent moves5 records

Expansion highlights4 records

Direct peers

• Indian Immunologicals Limited: Indian government-affiliated veterinary and human vaccine manufacturer with a similarly broad portfolio of livestock and poultry vaccines sold across emerging markets. Closely comparable to JOVAC in scale, government backing, institutional/governmental GTM, and biologics focus.
• Bioveta, a.s. Czech veterinary vaccine and pharmaceutical manufacturer with broad livestock and poultry vaccine portfolio and export reach across EMEA. Highly comparable to JOVAC in technology platforms (live + inactivated) and mid-sized regional manufacturer profile.
• Hester Biosciences Limited: India-based veterinary vaccine manufacturer with poultry and large animal vaccine lines and significant emerging-market exports. Comparable to JOVAC in product breadth (live and inactivated vaccines), emerging-market distribution, and small-to-mid cap profile.
• Laboratorios HIPRA, S.A. Spanish veterinary biopharmaceutical company specializing in vaccines for livestock and aquaculture with strong international distribution. Comparable to JOVAC in biologics specialization, technology breadth, and export-driven model.

Regional players

• Biovet JSC: Bulgarian veterinary vaccine manufacturer producing live and inactivated vaccines for poultry and livestock, exporting primarily across Eastern Europe, Middle East and Africa. Comparable in scale, technology platform, and regional export model.

Broad incumbents

• Zoetis Inc. Largest global animal health company, with comprehensive livestock and poultry vaccine franchises that compete head-to-head with JOVAC in government and institutional tenders worldwide.
• Merck Animal Health (MSD Animal Health): Global animal-health division of Merck offering poultry and livestock vaccines with strong emerging-market footprint. Overlaps JOVAC in NDV, IB, IBD, and large-animal vaccine categories across the same 48-country footprint.
• Ceva Santé Animale: Global top-five animal health company with a major poultry and livestock vaccine franchise including avian influenza. Overlaps with JOVAC in poultry vaccines, inactivated/live platforms, and emerging-market distribution, but at much greater scale.
• Boehringer Ingelheim Animal Health: Global animal health major with deep livestock and poultry vaccine portfolio, including avian influenza. Directly competes with JOVAC's inactivated Avian Influenza vaccines in tenders across MENA/Africa and Asia.

Emerging players

• Vaxxinova International B.V. Mid-sized European veterinary vaccine specialist focused on autogenous and conventional livestock and poultry vaccines, with growing emerging-market reach. Comparable niche scale and product overlap with JOVAC.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• Xx.com/tweet
• Facebookfacebook.com/share.php
• LinkedInlinkedin.com/company/jordan-bio-industries-center

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about JORDAN BIO-INDUSTRIES CENTER